[HTML] nih.gov

[HTML][HTML] PROTACs are effective in addressing the platelet toxicity associated with BCL-XL inhibitors

P Zhang, X Zhang, X Liu, S Khan, D Zhou… - Exploration of targeted …, 2020 - ncbi.nlm.nih.gov
Abstract BCL-X L is an anti-apoptotic protein that plays an important role in tumorigenesis,
metastasis, and intrinsic or therapy-induced cancer drug resistance. More recently, BCL-X L …
被引用次数：19 相关文章

PROTACs are effective in addressing the platelet toxicity associated with BCL-XL inhibitors

P Zhang, X Zhang, X Liu, S Khan… - … of Targeted Anti …, 2020 - scholars.uthscsa.edu
Abstract BCL-X L is an anti-apoptotic protein that plays an important role in tumorigenesis,
metastasis, and intrinsic or therapy-induced cancer drug resistance. More recently, BCL-X L …
[HTML] nih.gov

[HTML][HTML] PROTACs are effective in addressing the platelet toxicity associated with BCL-XL inhibitors

P Zhang, X Zhang, X Liu, S Khan, D Zhou… - Exploration of targeted …, 2020 - ncbi.nlm.nih.gov
Abstract BCL-X L is an anti-apoptotic protein that plays an important role in tumorigenesis,
metastasis, and intrinsic or therapy-induced cancer drug resistance. More recently, BCL-X L …
[PDF] academia.edu

[PDF][PDF] PROTACs are effective in addressing the platelet toxicity associated with BCL-X

P Zhang, X Zhang, X Liu, S Khan, D Zhou, G Zheng - 2020 - academia.edu
BCL-XL is an anti-apoptotic protein that plays an important role in tumorigenesis, metastasis,
and intrinsic or therapy-induced cancer drug resistance. More recently, BCL-XL has also …

PROTACs are effective in addressing the platelet toxicity associated with BCL-XL inhibitors.

P Zhang, X Zhang, X Liu, S Khan, D Zhou… - Exploration of Targeted …, 2020 - europepmc.org
Abstract BCL-X L is an anti-apoptotic protein that plays an important role in tumorigenesis,
metastasis, and intrinsic or therapy-induced cancer drug resistance. More recently, BCL-X L …
[HTML] explorationpub.com

[HTML][HTML] PROTACs are effective in addressing the platelet toxicity associated with BCL-XL inhibitors

P Zhang, X Zhang, X Liu, S Khan… - … of Targeted Anti …, 2020 - explorationpub.com
Abstract BCL-X L is an anti-apoptotic protein that plays an important role in tumorigenesis,
metastasis, and intrinsic or therapy-induced cancer drug resistance. More recently, BCL-X L …

PROTACs are effective in addressing the platelet toxicity associated with BCL-XL inhibitors

P Zhang, X Zhang, X Liu, S Khan… - … of targeted anti …, 2020 - pubmed.ncbi.nlm.nih.gov
BCL-X L is an anti-apoptotic protein that plays an important role in tumorigenesis,
metastasis, and intrinsic or therapy-induced cancer drug resistance. More recently, BCL-X L …

PROTACs are effective in addressing the platelet toxicity associated with BCL-XL inhibitors.

P Zhang, X Zhang, X Liu, S Khan, D Zhou… - Exploration of Targeted …, 2020 - europepmc.org
Abstract BCL-X L is an anti-apoptotic protein that plays an important role in tumorigenesis,
metastasis, and intrinsic or therapy-induced cancer drug resistance. More recently, BCL-X L …